|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Esperion Therapeutics (NASDAQ: ESPR) through any online brokerage.
The latest price target for Esperion Therapeutics (NASDAQ: ESPR) was reported by Credit Suisse on May 5, 2021. The analyst firm set a price target for 36.00 expecting ESPR to rise to within 12 months (a possible 61.87% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Esperion Therapeutics (NASDAQ: ESPR) is $22.24 last updated Wed Jun 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Esperion Therapeutics.
There is no upcoming split for Esperion Therapeutics.
Esperion Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.